Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration is a research paper published in GeroScience (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: I01BX002619
NIH HHS
Grant: P40 OD010440
NIA NIH HHS
Grant: R01 AG066729
BLRD VA
Grant: I01 BX004044
BLRD VA
Grant: IK2 BX004341
National Institutes of Health
Grant: 1R01AG066729-01A1
TDP-43 in Alzheimer's disease
National Institutes of Health
Grant: 1P40OD010440-01
Caenorhabditis Genetics Center
National Institutes of Health
Grant: 5I01BX002619-02
Identifying new tau targeted therapeutics: a drug repurposing approach
National Institutes of Health
Grant: 5I01BX004044-04
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS
National Institutes of Health
Grant: 1RF1AG055474-01
MSUT2 modulates pathological tau in AD and model organisms
FWCI
1.30
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals